Gut Bacteria Drive Heart Disease Through Inflammatory Pathways Beyond Cholesterol

Atherosclerosis, the underlying cause of heart attacks and strokes, has traditionally been viewed as a cholesterol-driven disease. However, this review demonstrates that gut bacteria play an equally important role in cardiovascular health through inflammation and metabolic pathways independent of lipids.

Researchers analyzed clinical studies showing that people with cardiovascular disease have distinctly altered gut microbiomes, including increased presence of oral bacteria in their intestines. These microbial changes aren't just coincidental—they actively contribute to disease development.

The gut produces various metabolites that either harm or protect blood vessels. Harmful compounds like endotoxin, trimethylamine N-oxide (TMAO), and imidazole propionate promote arterial inflammation and plaque formation. Conversely, certain tryptophan-derived metabolites appear protective against atherosclerosis.

Crucially, gut bacteria interact extensively with lipid metabolism, affecting how fats are absorbed and stored. They also contribute to vascular aging processes, creating a complex web of interactions between microbes, metabolism, and cardiovascular health.

Preclinical studies using prebiotics, probiotics, and targeted antibiotics show promising results for preventing atherosclerosis, suggesting practical interventions may be possible. This research positions the gut microbiome as a "rheostat" controlling vascular inflammation—a dial that could potentially be adjusted therapeutically to prevent heart disease and stroke.